ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited
Whether they sold following the November 9, 2026 disclosure or continue to hold their shares, Zura Bio shareholders who suffered losses after the Company announced that its Phase 2 TibuSHIELD trial failed to meet its primary endpoint may be eligible to seek recovery. NEW YORK, Nov. 10,...